SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-058394
Filing Date
2017-11-13
Accepted
2017-11-13 16:34:06
Documents
1
Period of Report
2017-11-09
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv479183_8k.htm 8-K 24842
  Complete submission text file 0001144204-17-058394.txt   26285
Mailing Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601
Business Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36641 | Film No.: 171196427
SIC: 2836 Biological Products, (No Diagnostic Substances)